Terns Pharmaceuticals Appoints Ankang Li, Ph.D., J.D., CFA as Chief Financial Officer

FOSTER CITY, Calif. & SHANGHAI, July 1 (Bernama-BUSINESS WIRE) — Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat non-alcoholic steatohepatitis (NASH) and cancer, announced today the appointment of Ankang Li, Ph.D., J.D., CFA as Chief Financial Officer.

http://mrem.bernama.com/viewsm.php?idm=34883